Zerumbone inhibits growth of hormone refractory prostate cancer cells by inhibiting JAK2/STAT3 pathway and increases paclitaxel sensitivity
Year: 2014
Type: article
Source: Anti-Cancer Drugs
Authors: Jessica E. Jorvig, Arup Chakraborty
Institution: Roseman University of Health Sciences
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2312947175
